Offstream
news

---

Changes

1. Kyrgyzstan receives documents for the Pfizer vaccine.
   2021-01-13 01:05:28 (First version)
2. Kyrgyzstan receives documents for Pfizer's vaccine.
   (Current version)

---

Related

Switzerland signs an agreement with Pfizer to supply a total of 14 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 and 2023, which also includes an option to supply an additional 7 million vaccine doses in subsequent years.
2021-08-25

The Biden administration announces that the United States has purchased 200 million extra doses of the vaccine developed by Pfizer and BioNTech, including doses intended for children under the age of 12 years old.
2021-07-23

The U.S. Food and Drug Administration says that it has granted priority review for the vaccine developed by Pfizer and BioNTech. A decision on whether to fully approve the vaccine will likely be made within two months.
2021-07-16

The European Commission signs a new deal with Pfizer and BioNTech to purchase 900 million doses of its vaccine with an additional option to purchase another 900 million doses for delivery from 2021 to 2023 which they intend to use as booster shots against the illness and to allow for the vaccination of children and teenagers.
2021-05-8

Governor Charlie Baker receives his first dose of the Pfizer vaccine.
2021-04-6

Brazil signs a deal with Pfizer to purchase 100 million doses of the Pfizer–BioNTech vaccine.
2021-03-15

The government announces a deal with Pfizer to receive 14 million doses of its COVID-19 vaccine by June, and a total of 99 million doses by the end of the year.
2021-03-8

Novartis signs an agreement with Pfizer and BioNTech to help produce their vaccine.
2021-01-29

Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses.
2021-01-12

Pfizer announces that it has submitted their vaccine for approval in India.
2020-12-5